Yanping Wu
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- RNA Interference and Gene Delivery 3
- Kruppel-like factors research 3
- Circular RNAs in diseases 3
- RNA modifications and cancer 3
- Ubiquitin and proteasome pathways 2
- Oncology 7
- Co-authors
- Xinmin Liu (10 shared papers)Xiaowei Zeng (3 shared papers)Laiqiang Huang (7 shared papers)Kewei Liu (3 shared papers)Lin Mei (2 shared papers)Yongfeng Gao (2 shared papers)Zhongyuan Wang (2 shared papers)Huijun Zhu (2 shared papers)
- Journals
- Scientific Reports (5 papers)Acta Pharmaceutica Sinica B (3 papers)Biomaterials (2 papers)International Journal of Molecular Medicine (2 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Yanping Wu
50 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 109
- Biomaterials 200
- Neurology 78
- Cancer Research 124
- Pharmaceutical Science 50
- Rehabilitation 44
Countries citing papers authored by Yanping Wu
This map shows the geographic impact of Yanping Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanping Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanping Wu more than expected).
Fields of papers citing papers by Yanping Wu
This network shows the impact of papers produced by Yanping Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanping Wu. The network helps show where Yanping Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yanping Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 209 | |
| 2 | 2018 | 99 | |
| 3 | 2013 | 92 | |
| 4 | 2007 | 74 | |
| 5 | 2014 | 54 | |
| 6 | 2018 | 47 | |
| 7 | 2017 | 42 | |
| 8 | 2019 | 31 | |
| 9 | 2019 | 30 | |
| 10 | 2018 | 28 | |
| 11 | 2020 | 26 | |
| 12 | 2022 | 24 | |
| 13 | 2019 | 24 | |
| 14 | 2011 | 21 | |
| 15 | 2020 | 16 | |
| 16 | Semaphorin 3A deficiency improves hypoxia-induced myocardial injury via resisting inflammation and cardiomyocytes apoptosis. | 2016 | 15 |
| 17 | 2021 | 14 | |
| 18 | 2019 | 13 | |
| 19 | 2016 | 12 | |
| 20 | 2023 | 10 |
About Yanping Wu
Yanping Wu is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 60 papers that have together received 1.0k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (3 papers), Kruppel-like factors research (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Circular RNAs in diseases (3 papers), MicroRNA in disease regulation (3 papers), RNA modifications and cancer (3 papers), Nanoplatforms for cancer theranostics (3 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Biomaterials (200 citations), Neurology (78 citations), Cancer Research (124 citations), Pharmaceutical Science (50 citations) and Rehabilitation (44 citations). Yanping Wu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Xinmin Liu, Xiaowei Zeng, Laiqiang Huang, Kewei Liu, Lin Mei, Yongfeng Gao, Zhongyuan Wang, Huijun Zhu, Xudong Zhang and Lianjun Lin. Their work appears in journals such as Scientific Reports, Acta Pharmaceutica Sinica B, Biomaterials, International Journal of Molecular Medicine and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.